Publications

Preventing chronic disease

The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004-2015.

25-08-2016

The New England journal of medicine

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

25-08-2016

Cell reports

PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.

23-08-2016

Oncology

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

22-08-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

20-08-2016

Oncogene

A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

18-08-2016

Oncogenesis

RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment.

15-08-2016

International journal of cancer

BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.

15-08-2016

Oncogene

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

11-08-2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

10-08-2016

Breast cancer research : BCR

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

05-08-2016

Oncogene

Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

04-08-2016

BMC cancer

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

02-08-2016

Current opinion in immunology

Neoantigens encoded in the cancer genome.

01-08-2016

World journal of urology

Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.

01-08-2016

PLoS medicine

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

01-08-2016

Nuclear medicine communications

A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.

01-08-2016

Breast cancer research and treatment

Predictors of enduring clinical distress in women with breast cancer.

01-08-2016

Psycho-oncology

Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer?

01-08-2016

Journal of biomedical optics

Navigation of a robot-integrated fluorescence laparoscope in preoperative SPECT/CT and intraoperative freehand SPECT imaging data: a phantom study.

01-08-2016

Journal of pharmaceutical analysis

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar.

01-08-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.

01-08-2016

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.

01-08-2016

The Lancet. Oncology

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

01-08-2016

Annals of oncology : official journal of the European Society for Medical Oncology

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies.

01-08-2016

International journal of computer assisted radiology and surgery

Comparing position and orientation accuracy of different electromagnetic sensors for tracking during interventions.

01-08-2016

Current opinion in immunology

Editorial overview: Cancer immunology: genomics & biomarkers: Cancer immunity through the prism of genomics and proteomics.

01-08-2016

European journal of cancer (Oxford, England : 1990)

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.

01-08-2016

World journal of urology

Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.

01-08-2016

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Effects of anatomical changes on pencil beam scanning proton plans in locally advanced NSCLC patients.

01-08-2016

Journal of structural biology

Structural snapshots of the catalytic cycle of the phosphodiesterase Autotaxin.

01-08-2016

Oncoimmunology

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination.

01-08-2016

Journal of epidemiology and community health

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

01-08-2016

Annals of surgical oncology

(Near-Infrared) Fluorescence-Guided Surgery Under Ambient Light Conditions: A Next Step to Embedment of the Technology in Clinical Routine.

01-08-2016

Cancer research

We Are Standing on the Shoulders of Giants.

01-08-2016

Cancer research

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.

01-08-2016

Menopause (New York, N.Y.)

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

01-08-2016

Journal of clinical epidemiology

Content validity across methods of malnutrition assessment in patients with cancer is limited.

01-08-2016

The oncologist

Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.

01-08-2016

Psycho-oncology

Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.

01-08-2016

Human reproduction (Oxford, England)

Women's adjustment trajectories during IVF and impact on mental health 11-17 years later.

01-08-2016

Lung cancer (Amsterdam, Netherlands)

Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback.

01-08-2016

Radiation research

Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for Radioprotectors.

01-08-2016

Annals of oncology : official journal of the European Society for Medical Oncology

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

01-08-2016

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers.

01-08-2016

PloS one

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

28-07-2016

Cell

A Landscape of Pharmacogenomic Interactions in Cancer.

28-07-2016

Bladder cancer (Amsterdam, Netherlands)

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer.

27-07-2016

J Clin Invest: The Journal of clinical investigation

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

25-07-2016

Journal of translational medicine

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.

25-07-2016

The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004-2015.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment.

BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.

Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

Neoantigens encoded in the cancer genome.

Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.

Predictors of enduring clinical distress in women with breast cancer.

Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer?

Navigation of a robot-integrated fluorescence laparoscope in preoperative SPECT/CT and intraoperative freehand SPECT imaging data: a phantom study.

Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar.

FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.

Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies.

Comparing position and orientation accuracy of different electromagnetic sensors for tracking during interventions.

Editorial overview: Cancer immunology: genomics & biomarkers: Cancer immunity through the prism of genomics and proteomics.

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.

Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.

Effects of anatomical changes on pencil beam scanning proton plans in locally advanced NSCLC patients.

Structural snapshots of the catalytic cycle of the phosphodiesterase Autotaxin.

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).

(Near-Infrared) Fluorescence-Guided Surgery Under Ambient Light Conditions: A Next Step to Embedment of the Technology in Clinical Routine.

We Are Standing on the Shoulders of Giants.

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

Content validity across methods of malnutrition assessment in patients with cancer is limited.

Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.

Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.

Women's adjustment trajectories during IVF and impact on mental health 11-17 years later.

Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback.

Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for Radioprotectors.

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers.

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

A Landscape of Pharmacogenomic Interactions in Cancer.

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer.

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.

This site uses cookies